TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
GLRE

Greenlight Capital Re Ltd

Financial Services · Insurance - Reinsurance · listed since 2007

15.10$ -0.5% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

Yellow, because substance and structure contradict each other. Green is ruled out by the lack of standalone operating strength: in both of the last two years the result was carried mainly by the securities portfolio — $60.2 million against $35.7 million in 2025, $79.6 million against minus $8.2 million in 2024 — and that portfolio is managed by an entity of the chairman of the board on hedge fund terms for most recently $10.9 million a year. Add reserve strengthening on prior-year claims of $11.4 million and $21.8 million, plus buybacks of which a third has gone directly to a family trust of the chairman since 01.06.2026. Red is ruled out by the absence of any substance finding: equity rose $72.1 million to $708.0 million during 2025, book value per share grew 13.8 percent, the loans are repaid, the combined ratio sits below 100 percent, and A.M. Best raised its rating to A (Excellent). This is a judgment on the company, not on the share price. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Greenlight Capital Re is two businesses in one share: a reinsurer that earns again after weak years — combined ratio 94.6 percent after 101.4 — and a securities portfolio that contributed $60.2 million to the 2025 result against $35.7 million from underwriting. That portfolio is managed by an entity of the chairman of the board, which received $10.9 million for it. The metric that put the name on our list measures nothing distributable at an insurer; the fitting measure is book value per share, and there the stock trades at 0.79 times. Not investment advice.

Underwriting

The combined ratio fell to 94.6 percent in 2025 from 101.4 percent, and to 96.0 from 104.6 percent in the first quarter of 2026. A loss of $8.2 million turned into income of $35.7 million. Gross premiums rose 10.7 percent to $773.3 million, and A.M. Best raised its rating to A (Excellent).

Dependence on the portfolio

Investment income contributed $60.2 million to the 2025 result against $35.7 million from underwriting; in 2024, at $79.6 million, it was the only positive contribution. The group is contractually obliged to place substantially all of its investable assets in a single fund.

Conflict of interest and fees

The fund is managed by an entity of the chairman of the board on hedge fund terms: a 1.5 percent management fee and a 20 percent performance allocation, currently reduced to 10 percent. That cost $10.9 million in 2025, after $9.8 million and $8.0 million in the prior years. On top of that, since 01.06.2026 the company buys a third of every buyback directly from a family trust of the chairman.

Balance sheet and capital

Equity rose $72.1 million during 2025 to $708.0 million. The loans were fully repaid; only $5.0 million on a credit facility was outstanding at 31.12.2025, and interest coverage stood at roughly 19 times. The Altman insolvency early-warning score is deliberately not used here — the formula was not built for insurers.

Reserves

Re-estimating prior-year claims cost $11.4 million in 2025 and $21.8 million in 2024 — considerable against underwriting income of $35.7 million in 2025. In the first quarter of 2026 the line turned positive for the first time, at a gain of $1.6 million.

Hook and data quality

47th of 545 U.S. hits in the in-house P/FCF ranking at 2.19, measured identically on both editions on 27.07.2026 — outside the 25 rows displayed and visible only through the screener or the company page. The metric itself is not used for valuation in this article: at an insurer it measures premiums collected that are future obligations. The market value carried in the data set, $0.518 billion, sits roughly 8 percent below our own calculation from the cover page share count and the price ($564 million).

Worth Noting

Hook and source: 47th of 545 U.S. hits in the in-house P/FCF ranking at a value of 2.19, measured live on July 27, 2026 and identical on both editions; the German list covering all markets counted 836 hits the same day. Only the 25 strongest rows are displayed — Greenlight Re is not among them and has to be found through the screener or the company page. The lists are recalculated daily.

Why the hook metric is not used for valuation in the article: at a reinsurer, operating cash flow consists largely of premiums for claims not yet paid. Of $210.2 million in 2025, $107.0 million came from the increase in loss reserves and $37.2 million from higher unearned premiums. Used instead is the price-to-book ratio, which the company itself names as its guiding measure.

Why we calculated the market value ourselves: the value carried in the data set, $0.518 billion, sits roughly 8 percent below the calculation from the share count on the 10-Q cover page (33,166,448 as of 30.04.2026) and the closing price of $16.99 on 24.07.2026, which gives $564 million.

On the Altman score: our data set carries a value of 4.13 for GLRE. It is deliberately not used as evidence in the article, because the formula was developed for industrial and trading companies and at insurers draws on quantities that are not comparable there. The argument runs instead on equity, investments, reserve development, combined ratio and interest coverage.

On the distance from the high: our data set shows 52.8 percent. Calculated ourselves from the price series we get 51.5 percent against the highest closing price of $35.00 on 04.09.2014. The article uses the self-calculated figure.

Status of the mandatory checks on July 27, 2026: the most recent periodic report is the quarterly report for March 31, 2026 (filed 05.05.2026). The filing record contains no tender offer, no merger, no going-private transaction, no Form 15 and no Form 25. Filed after the quarterly report were the current report 8-K of 01.06.2026 (Item 1.01), a Schedule 13D/A of the same day, and insider and sale notices; all have been reviewed.

Risk of confusion: Greenlight Capital Re, Ltd. (GLRE, Nasdaq) is the listed reinsurer. Greenlight Capital, Inc. and DME Advisors, LP are separate entities from the orbit of David Einhorn; they manage the portfolio but are not themselves listed.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at GLRE since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 12.00 $ to 19.00 $ · Last price: 15.10 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.5$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 33m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.6%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.3

Performance

Perf. 1M ?Price performance over the last month. 4.80%
Perf. 3M ?Price performance over the last 3 months. -0.60%
Perf. 6M ?Price performance over the last 6 months. 13.80%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 12.80%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -17.1%
Perf. 1Y ?Price performance over the last 12 months. 18.97%
Perf. 3Y ?Price performance over the last 3 years. 33.42%
Perf. 5Y ?Price performance over the last 5 years. 107.59%
Perf. 10Y ?Price performance over the last 10 years. -24.94%
Perf. Since Inception ?Price performance since the first available trading day (05/24/2007) — with a complete history, that is since the IPO. -37.37%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 15.60$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 15.90$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 15.70$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 40.4
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 16.7%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 26.1%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 6.7
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 4.6
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 1.7
P/B ?Price-to-book ratio: market value relative to book equity. 0.7
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 0.7
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 0.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 2.5

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 12.4%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 7.4%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 11.5%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 1.8%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.01
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. 4.13
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 7 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -6.90%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 22.10%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 7.47%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee.
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. -15.80%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 49
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 67
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. D (29 out of 100)

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Insurance - Reinsurance

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Greenlight Capital Re Ltd GLRE 0.5 6.7 0.0 12.4 7.5 19.0
Reinsurance Group of America, Incorporated RGA 15.9 13.8 0.0 14.1 8.3 3.4 34.5
Everest Group Ltd EG 14.9 7.8 0.0 15.3 20.2 1.4 16.7
Renaissancere Holdings Ltd RNR 14.0 5.8 0.0 45.4 26.8 9.5 37.2
Hamilton Insurance Group, Ltd. HG 3.5 5.5 0.0 38.6 29.1 15.3 59.7
Siriuspoint Ltd SPNT 2.9 6.3 0.0 23.9 18.0 22.6 36.0
Kestrel Group Ltd KG 0.0 0.9 46.3 -97.1 785.1 -78.0
Median of companies shown 3.5 6.5 0.0 23.9 19.1 9.5 34.5

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 588 $M 2016 · Operating income: 47 $M 2016 · Net income: 45 $M 2017 · Revenue: 646 $M 2017 · Operating income: -45 $M 2017 · Net income: -45 $M 2018 · Revenue: 244 $M 2018 · Operating income: -354 $M 2018 · Net income: -350 $M 2019 · Revenue: 491 $M 2019 · Operating income: -4 $M 2019 · Net income: -4 $M 2020 · Revenue: 479 $M 2020 · Operating income: 4 $M 2020 · Net income: 4 $M 2021 · Revenue: 570 $M 2021 · Operating income: 21 $M 2021 · Net income: 18 $M 2022 · Revenue: 478 $M 2022 · Operating income: 25 $M 2022 · Net income: 25 $M 2023 · Revenue: 632 $M 2023 · Operating income: 87 $M 2023 · Net income: 87 $M 2024 · Revenue: 648 $M 2024 · Operating income: 44 $M 2024 · Net income: 43 $M 2025 · Revenue: 696 $M 2025 · Operating income: 78 $M 2025 · Net income: 75 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 588 47 45 1.20 -36 874 2,665
2017 646 -45 -45 -1.21 94 851 3,357
2018 244 -354 -350 -9.74 -59 477 1,435
2019 491 -4 -4 -0.11 2 477 1,355
2020 479 4 4 0.11 -91 465 1,358
2021 570 21 18 0.51 -56 476 1,427
2022 478 25 25 0.64 -32 503 1,580
2023 632 87 87 2.50 8 596 1,735
2024 648 44 43 1.24 112 636 2,016
2025 696 78 75 2.17 210 708 2,170

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 141.8 $M Q4 2025: Q1 · 213.3 $M Q1 2025: Q2 · 160.1 $M Q2 2025: Q3 · 146.1 $M Q3 2025: Q4 · 210.3 $M Q4 2026: Q1 · 189.7 $M Q1 2026: Q2 · 137.5 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.81 -262.60 142 -8.80 -20.10 30 30
2025: Q1 0.86 10.40 213 11.50 13.90 10 10
2025: Q2 0.01 -95.80 160 -8.50 0.20 68 68
2025: Q3 -0.13 -112.90 146 -22.30 -3.00 31 31
2025: Q4 1.43 210 48.30 27.70 100 100
2026: Q1 1.05 21.50 190 -11.10 18.80 37 37
2026: Q2 -0.89 -9,000.00 138 -14.10 -21.50 31 31

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 7 of our scanner strategies — each hit links to the scanner.

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus
Analyst Ratings
Price Target (average) 1.00$
Distance to price -93.4% The price target sits 93.4% below the current price.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

With these assumptions (discount rate 10.0%, terminal growth 2.5%), no growth rate between -20.0% and 60.0% per year explains today’s market value — the reverse calculation yields no meaningful figure here.

What is priced in?
Free cash flow (last twelve months) $200.0M
Market cap $490.0M
Free cash flow in year ten
Terminal value as a share of market value

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Greenlight Re verkauft keine KI-Funktionen und weist keinen KI-Umsatz aus: In sechs geprüften Berichten (zwei Geschäftsberichte, vier Quartalsberichte) kommt künstliche Intelligenz ausschließlich im Geschäftsbericht 2025 vor — als interne Nutzungsrichtlinie und als Verstärker des Cyberrisikos; im jüngsten Quartalsbericht zum 31.03.2026 fällt der Begriff kein einziges Mal. Kein Produkt, kein Segment und keine Umsatzangabe ist mit KI verknüpft.

View the full file — quotes, sources, reviewed filings
„We are also monitoring use and potential uses of artificial intelligence (AI) tools across our business, and recently implemented an AI Usage Policy in order to establish guidelines for the ethical, secure, and compliant use of AI platforms by our employees"

Wir beobachten außerdem den Einsatz und mögliche Einsatzfelder von Werkzeugen der künstlichen Intelligenz in unserem gesamten Geschäft und haben kürzlich eine KI-Nutzungsrichtlinie eingeführt, um Leitlinien für den ethischen, sicheren und regelkonformen Umgang unserer Mitarbeiter mit KI-Plattformen festzulegen

10-K · 2026-03-09 · View SEC filing

„In addition, artificial intelligence technologies are evolving at a fast pace and being adopted, which may increase potential cybersecurity risks."

Zudem entwickeln sich Technologien der künstlichen Intelligenz rasch weiter und werden zunehmend eingesetzt, was potenzielle Cybersicherheitsrisiken erhöhen kann.

10-K · 2026-03-09 · View SEC filing

Filings Reviewed: 10-Q 2026-05-05 · 10-K 2026-03-09 · 10-Q 2025-11-03 · 10-Q 2025-08-04 · 10-Q 2025-05-07 · 10-K 2025-03-10

Rated on July 27, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

6 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years 13.4%
  • More than 10% revenue growth is expected for the coming year no data
  • Share count grows by less than 3% a year -4.6%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 37.7%
  • Gross margin at 40% or higher and without meaningful erosion 40.9%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 107 m net cash
  • Operating cash flow covers the profits of the last three years 125 m
  • Return on capital at 15% or higher, or up versus two years ago 10.8%
  • Insiders hold at least 10% or are net buyers 24.6%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

2/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 1.9%
  • Exp. sales growth 3Y > 5%
  • EBIT growth 10Y > 5% 5.8%
  • Exp. EBIT growth 3Y > 5%
  • Net debt < 4x EBIT -1.4x
  • EBIT positive, 10Y straight 7
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 12.3%
  • ROCE > 15% 10.8%
  • Expected return > 10%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Isaacs Ian Director Sell 4,850 15.13 73,358
Sep 3, 2026 Welch John Director Other 13,356 0.00
Aug 28, 2026 Isaacs Ian Director Sell 4,054 15.42 62,522
Aug 27, 2026 Isaacs Ian Director Sell 946 15.43 14,596
Aug 10, 2026 Goldberg Leonard R Director Buy 6,000 15.42 92,520
Aug 7, 2026 Goldberg Leonard R Director Buy 6,000 15.62 93,720
Aug 7, 2026 Foley Ursuline F Director Other 7,992 0.00
Aug 7, 2026 Platt Joseph P JR Director Other 7,992 0.00
Aug 7, 2026 Guest Victoria W Director Other 7,992 0.00
Aug 7, 2026 Warszawski Ariel Director Other 14,386 0.00

View all insider transactions →

The company

About the Company

Greenlight Capital Re, Ltd. ist über seine Tochtergesellschaften weltweit ein Sach- und Schadenrückversicherungsunternehmen.

Employees
84
Headquarters
Grand Cayman, Cayman Islands
Address
65 Market Street, KY1-1205 Grand Cayman, Cayman Islands
Phone
345 943 4573
IPO Date
05/24/2007
ISIN
KYG4095J1094

Management

Management
Name Title Birth Year
Greg Richardson CEO & Director 1960
Faramarz Romer Chief Financial Officer 1977
Patrick O'Brien Chief Operating Officer 1970
Thomas James Curnock Ph.D. Group Chief Underwriting Officer 1972
Brian O'Reilly Head of Innovations 1985
Steven Archambault Chief Accounting Officer 1971
Adam Prior Senior Vice President of Equity Group Inc.
David E. Sigmon General Counsel, Corporate Secretary & Chief Compliance Officer 1984
Simon Burton Advisor 1970
Kagabo Ngiruwonsanga Head of Innovation Underwriting

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/01/2026 GREENLIGHT CAPITAL RE, LTD. (GLRE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits SEC ↗
  • 08/04/2026 GREENLIGHT CAPITAL RE, LTD. (GLRE): Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 08/03/2026 GREENLIGHT CAPITAL RE, LTD. (GLRE): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?